Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-157 | TNBC | Basal B | Cisplatin | DNA cross-linker | DNA cross-linker | 10 | uM | 10093.021 | 0.7802 | 0.5258 | 0.9172 | |
MDA-MB-157 | TNBC | Basal B | Cisplatin | DNA cross-linker | DNA cross-linker | 50 | uM | 10093.021 | 0.4504 | -0.1619 | 0.9172 | |
MDA-MB-157 | TNBC | Basal B | Cisplatin | DNA cross-linker | DNA cross-linker | 250 | uM | 10093.021 | 0.0121 | -0.9838 | 0.9172 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.00064 | uM | 7885.017 | 1.0055 | 1.0197 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.0032 | uM | 7885.017 | 0.9813 | 0.9341 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.016 | uM | 7885.017 | 0.9979 | 0.9924 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.08 | uM | 7885.017 | 0.8993 | 0.6572 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.4 | uM | 7885.017 | 0.9866 | 0.9526 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 2 | uM | 7885.017 | 0.9173 | 0.7165 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 10 | uM | 7885.017 | 0.7183 | 0.1131 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 50 | uM | 7885.017 | 0.2376 | -0.8430 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 250 | uM | 7885.017 | 0.0624 | -0.9853 | 0.5647 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.00064 | uM | 7886.017 | 0.9721 | 0.9232 | 0.7230 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.0032 | uM | 7886.017 | 1.0121 | 1.0335 | 0.7230 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.016 | uM | 7886.017 | 1.0499 | 1.1393 | 0.7230 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.08 | uM | 7886.017 | 1.0081 | 1.0223 | 0.7230 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.4 | uM | 7886.017 | 0.9839 | 0.9556 | 0.7230 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 2 | uM | 7886.017 | 0.9024 | 0.7353 | 0.7230 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 10 | uM | 7886.017 | 0.5854 | -0.0463 | 0.7230 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 50 | uM | 7886.017 | 0.2041 | -0.7780 | 0.7230 | |
MDA-MB-175-VII | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 250 | uM | 7886.017 | 0.0169 | -0.9929 | 0.7230 | |
MDA-MB-231 | TNBC | Basal B | Cisplatin | DNA cross-linker | DNA cross-linker | 0.00064 | uM | 7892.017 | 1.0255 | 1.0207 | 2.4495 | |
MDA-MB-231 | TNBC | Basal B | Cisplatin | DNA cross-linker | DNA cross-linker | 0.0032 | uM | 7892.017 | 1.0591 | 1.0474 | 2.4495 | |
MDA-MB-231 | TNBC | Basal B | Cisplatin | DNA cross-linker | DNA cross-linker | 0.016 | uM | 7892.017 | 1.0716 | 1.0572 | 2.4495 | |
MDA-MB-231 | TNBC | Basal B | Cisplatin | DNA cross-linker | DNA cross-linker | 0.08 | uM | 7892.017 | 0.9653 | 0.9714 | 2.4495 |